VERASTEM INC (VSTM) Stock Fundamental Analysis

USA • Nasdaq • NASDAQ:VSTM • US92337C2035

6.75 USD
+0.45 (+7.14%)
Last: Feb 4, 2026, 03:55 PM
Fundamental Rating

1

Overall VSTM gets a fundamental rating of 1 out of 10. We evaluated VSTM against 524 industry peers in the Biotechnology industry. VSTM may be in some trouble as it scores bad on both profitability and health. VSTM is quite expensive at the moment. It does show a decent growth rate.


Dividend Valuation Growth Profitability Health

0

1. Profitability

1.1 Basic Checks

  • In the past year VSTM has reported negative net income.
  • VSTM had a negative operating cash flow in the past year.
  • In the past 5 years VSTM always reported negative net income.
  • VSTM had a negative operating cash flow in each of the past 5 years.
VSTM Yearly Net Income VS EBIT VS OCF VS FCFVSTM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 -50M -100M

1.2 Ratios

  • VSTM has a Return On Assets of -73.87%. This is in the lower half of the industry: VSTM underperforms 63.93% of its industry peers.
Industry RankSector Rank
ROA -73.87%
ROE N/A
ROIC N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
VSTM Yearly ROA, ROE, ROICVSTM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K -2K

1.3 Margins

  • The Profit Margin and Operating Margin and Gross Margin are not available for VSTM so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
VSTM Yearly Profit, Operating, Gross MarginsVSTM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1K -2K -3K

More info and screens

2

2. Health

2.1 Basic Checks

  • VSTM does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, VSTM has more shares outstanding
  • Compared to 5 years ago, VSTM has more shares outstanding
  • VSTM has a worse debt/assets ratio than last year.
VSTM Yearly Shares OutstandingVSTM Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
VSTM Yearly Total Debt VS Total AssetsVSTM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

2.2 Solvency

  • VSTM has an Altman-Z score of -8.89. This is a bad value and indicates that VSTM is not financially healthy and even has some risk of bankruptcy.
  • VSTM's Altman-Z score of -8.89 is on the low side compared to the rest of the industry. VSTM is outperformed by 69.47% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -8.89
ROIC/WACCN/A
WACC8.91%
VSTM Yearly LT Debt VS Equity VS FCFVSTM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M -100M

2.3 Liquidity

  • A Current Ratio of 2.58 indicates that VSTM has no problem at all paying its short term obligations.
  • Looking at the Current ratio, with a value of 2.58, VSTM is doing worse than 69.47% of the companies in the same industry.
  • VSTM has a Quick Ratio of 2.55. This indicates that VSTM is financially healthy and has no problem in meeting its short term obligations.
  • With a Quick ratio value of 2.55, VSTM is not doing good in the industry: 67.56% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.58
Quick Ratio 2.55
VSTM Yearly Current Assets VS Current LiabilitesVSTM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M

More info and screens

4

3. Growth

3.1 Past

  • The earnings per share for VSTM have decreased strongly by -21.00% in the last year.
  • VSTM shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -10.55% yearly.
EPS 1Y (TTM)-21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%N/A

3.2 Future

  • The Earnings Per Share is expected to grow by 18.78% on average over the next years. This is quite good.
  • The Revenue is expected to grow by 121.18% on average over the next years. This is a very strong growth
EPS Next Y8.17%
EPS Next 2Y20.64%
EPS Next 3Y18.97%
EPS Next 5Y18.78%
Revenue Next Year237.98%
Revenue Next 2Y244.62%
Revenue Next 3Y192.14%
Revenue Next 5Y121.18%

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
VSTM Yearly Revenue VS EstimatesVSTM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2033 200M 400M 600M 800M
VSTM Yearly EPS VS EstimatesVSTM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 0 -5 -10 -15 -20

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VSTM. In the last year negative earnings were reported.
  • Also next year VSTM is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
VSTM Price Earnings VS Forward Price EarningsVSTM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 40 60

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VSTM Per share dataVSTM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 -1 -2 -3

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VSTM's earnings are expected to grow with 18.97% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.64%
EPS Next 3Y18.97%

More info and screens

0

5. Dividend

5.1 Amount

  • VSTM does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

VERASTEM INC

NASDAQ:VSTM (2/4/2026, 3:55:01 PM)

6.75

+0.45 (+7.14%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryBiotechnology
Earnings (Last)11-04
Earnings (Next)03-18
Inst Owners77.99%
Inst Owner Change2.38%
Ins Owners0.39%
Ins Owner Change1.17%
Market Cap520.76M
Revenue(TTM)10.00M
Net Income(TTM)-130.64M
Analysts85.33
Price Target16.45 (143.7%)
Short Float %23.56%
Short Ratio8.59
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-29.89%
Min EPS beat(2)-108.2%
Max EPS beat(2)48.42%
EPS beat(4)1
Avg EPS beat(4)-32.54%
Min EPS beat(4)-108.2%
Max EPS beat(4)48.42%
EPS beat(8)3
Avg EPS beat(8)-15.88%
EPS beat(12)6
Avg EPS beat(12)-9.72%
EPS beat(16)8
Avg EPS beat(16)-6.19%
Revenue beat(2)2
Avg Revenue beat(2)90.77%
Min Revenue beat(2)86.8%
Max Revenue beat(2)94.73%
Revenue beat(4)2
Avg Revenue beat(4)-4.62%
Min Revenue beat(4)-100%
Max Revenue beat(4)94.73%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.78%
PT rev (3m)4.03%
EPS NQ rev (1m)0%
EPS NQ rev (3m)16.47%
EPS NY rev (1m)0%
EPS NY rev (3m)-17.58%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)51.97%
Revenue NY rev (1m)0%
Revenue NY rev (3m)72.06%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 52.08
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-3.86
EYN/A
EPS(NY)-1.91
Fwd EYN/A
FCF(TTM)-1.83
FCFYN/A
OCF(TTM)-1.72
OCFYN/A
SpS0.13
BVpS-0.2
TBVpS-0.42
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -73.87%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-88.21%
ROA(5y)-74.8%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 1894.51%
Cap/Sales 82.79%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.58
Quick Ratio 2.55
Altman-Z -8.89
F-Score2
WACC8.91%
ROIC/WACCN/A
Cap/Depr(3y)35.9%
Cap/Depr(5y)41.04%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-21%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-125%
EPS Next Y8.17%
EPS Next 2Y20.64%
EPS Next 3Y18.97%
EPS Next 5Y18.78%
Revenue 1Y (TTM)N/A
Revenue growth 3Y69.6%
Revenue growth 5Y-10.55%
Sales Q2Q%N/A
Revenue Next Year237.98%
Revenue Next 2Y244.62%
Revenue Next 3Y192.14%
Revenue Next 5Y121.18%
EBIT growth 1Y-24.84%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5Y36.99%
FCF growth 1Y-92.03%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-80.75%
OCF growth 3YN/A
OCF growth 5YN/A

VERASTEM INC / VSTM FAQ

Can you provide the ChartMill fundamental rating for VERASTEM INC?

ChartMill assigns a fundamental rating of 1 / 10 to VSTM.


What is the valuation status for VSTM stock?

ChartMill assigns a valuation rating of 0 / 10 to VERASTEM INC (VSTM). This can be considered as Overvalued.


What is the profitability of VSTM stock?

VERASTEM INC (VSTM) has a profitability rating of 0 / 10.


What is the financial health of VERASTEM INC (VSTM) stock?

The financial health rating of VERASTEM INC (VSTM) is 2 / 10.